Manuel Corpas
Chief Scientist
Dr. Corpas is an experienced researcher and trainer.
Since 2017, he has been Chief Scientific Officer of Cambridge Precision Medicine Limited, a company focused on helping make genetics more accessible. Among his current activities, he is a tutor at the Institute of Continuing Education at the University of Cambridge as well as being Course Director Clinical Genetics and Personalised Medicine, Universidad Internacional de La Rioja (UNIR), Madrid, Spain. He is also Software Sustainability Institute Fellow, UK and a member of the Scientific programme committee of Wellcome Genome Campus Conference on Personal Genomics, Cambridge, UK.
Dr. Corpas is a prolific author and speaker, currently with ~50 authored scientific publications and the acclaimed ‘Perfect DNA’ book; a speculative futuristic novel exploring the ethical and social implications of personal genetic testing in society. His upcoming projects include the editorial of a topic on personal genomics in the Frontiers in Genetics journal.
Edmund Lehmann
Chief Executive
Ed has been Chief Executive of Cambridge Precision Medicine Limited since 2018, and is also the main investor in the company, facilitated by his fund, Provenca Capital. Ed’s passion for precision medicine, and genetics in particular, stems from a belief that more targeted healthcare can significantly improve outcomes, as well as reducing healthcare costs in the long run, providing a double benefit to society.
Ed is a co-author of several upcoming publications which focus on the application of precision medicine in the context of wellness and disease prevention; he plays a leading role in the development of methodologies around data science and big data analysis which have become central to the deployment of genetics for the benefit of individuals.
Outside work, Ed is Chairman of the board of ReachOut, a mentoring charity helping to improve the lives of disadvantaged young people in inner cities in London, Manchester, Liverpool and Oldham. He is also an active supporter of the Roundhouse Trust. Ed holds the bilingual Masters in Business Administration from IESE Business School in Spain.
Beatriz Marques
Head of Business Development
Bea joined the Cambridge Precision Medicine team in 2020, having built up extensive experience in project management, marketing and communications. Bea was born in Portugal, raised in the UK and has worked in Sao Paulo, Barcelona and London, shaping her into a creative and innovative professional.
Bea’s passion for genetics, and personalised healthcare more generally, comes from a belief that being informed is being empowered. She sees the emerging trend towards individualisation taking place in the world at large, and believes that the application of personalisation in the healthcare sector can facilitate individuals taking charge of their health and wellness, in partnership with their clinician.
She holds a first-class degree in International Relations and a Master’s in Marketing Management. Her passion for communication translates into helping organisations navigate through growth and create meaningful relationships with their customers. Bea is an optimist with the attitude that a problem is in-fact a solution waiting to be found.